Look for:

Our offer for

JOHNSON & JOHNSON


ISIN:
US4781601046
WKN:
478160104

2021/08/04 17:35:24
Price
171.50 USD
Difference -1.15% (-2.00)

General attributes

ISINUS4781601046
SymbolJNJ
ExchangeLondon Stock Exchange
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)385,543 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)169.00 USD (100)
Ask (Ask size)179.00 USD (100)
Open174.20 USD
High174.26 USD
Low174.20 USD
Close (prev. day)173.50 USD
VWAP174.203352 USD
Volume (pcs)1,360
Trading volume124,729.60
Number of trades15
Last size-

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Annual report: JOHNSON & JOHNSONPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Erste Group related products on underlying

Product type # products
Reverse convertibles 1

Recent research



2021/08/04 17:35:24
Price
171.50 USD
Difference -1.15% (-2.00)

General attributes

ISINUS4781601046
SymbolJNJ
ExchangeLondon Stock Exchange
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)385,543 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)169.00 USD (100)
Ask (Ask size)179.00 USD (100)
Open174.20 USD
High174.26 USD
Low174.20 USD
Close (prev. day)173.50 USD
VWAP174.203352 USD
Volume (pcs)1,360
Trading volume124,729.60
Number of trades15
Last size-

Performance and Risk

6M1Y3Y
Perf (%)+6.24%+16.95%-
Perf (abs.)+10.07+24.85-
Beta0.430.540.64
Volatility19.8820.3720.99
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)172.40 USD (827)
Ø price 30 days | Ø volume 30 days (pcs.)168.93 USD (8,807)
Ø price 100 days | Ø volume 100 days (pcs.)166.29 USD (12,285)
Ø price 250 days | Ø volume 250 days (pcs.)158.23 USD (8,407)
YTD High | date179.42 USD (2021/01/27)
YTD Low | date153.57 USD (2021/03/05)
52 Weeks High | date179.42 USD (2021/01/27)
52 Weeks Low | date135.44 USD (2020/10/30)

Erste Group related products on underlying

Product type # products
Reverse convertibles 1

All listings for JOHNSON & JOHNSON

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2021/08/0508:08146.60 EUR0.001
Duesseldorf2021/08/0512:00146.78 EUR0.006
Frankfurt2021/08/0511:36147.10 EUR0.056
Hamburg2021/08/0508:03146.76 EUR0.001
Hanover2021/08/0511:32147.02 EUR0.012
London Stock Exchange2021/08/0417:35171.50 USD0.1215
Munich2021/08/0508:04147.06 EUR0.001
NYSE2021/08/0422:10173.36 USD832.9463,579
SIX Swiss Exchange2019/11/1517:35145.00 CHF0.001
SIX Swiss Exchange2020/03/3017:35150.00 USD0.001
Stuttgart2021/08/0511:09146.94 EUR0.052
Tradegate2021/08/0512:17146.90 EUR0.3671
Vienna Stock Exchange2021/08/0509:05146.82 EUR0.001
Xetra2021/08/0512:16147.06 EUR0.1444

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2419&ID_TYPE_IMAGE_LOGO=2

Contact Details

JOHNSON & JOHNSON
- -
One Johnson & Johnson Plaza - 08933 New Brunswick
Telefon: 1-732-524-0400
Fax: -
E-mail: -

PDF Downloads

Annual report: JOHNSON & JOHNSONPDF Download

Company Profile

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Members of Management Board

A. WashingtonMember of Board of Directors
Jennifer DoudnaMember of Board of Directors
Mark McClellanMember of Board of Directors
Mary BeckerleMember of Board of Directors
Nadja WestMember of Board of Directors
Anne MulcahyMember of Board of Directors
Charles PrinceMember of Board of Directors
D. DavisMember of Board of Directors
Hubert JolyMember of Board of Directors
Ian DavisMember of Board of Directors
Marillyn HewsonMember of Board of Directors
Mark WeinbergerMember of Board of Directors
Ronald WilliamsMember of Board of Directors
Alex GorskyChairman of Managing Board
Peter M. FasoloMember of Executive Committee
Ashley McEvoyMember of Executive Committee
Jennifer TaubertMember of Executive Committee
Joaquin DuatoMember of Executive Committee
Joseph WolkMember of Executive Committee
Kathryn E. WengelMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.